HOME BANCORP, INC. ANNOUNCES 2026 THIRD QUARTER RESULTS AND DECLARES QUARTERLY DIVIDEND

Home Bancorp reported Q3 2026 net income of $10.1 million, or $1.28 diluted EPS, down from $11.6 million and $1.48 in Q2. Net interest income edged up $110,000 to $35.9 million, but net interest margin fell 5 bps to 4.19%; nonperforming assets rose 37% to $53.7 million, or 1.49% of assets, after six loan relationships totaling $19.5 million moved to nonaccrual. The company declared a $0.32-per-share quarterly dividend, payable Nov. 13, 2026.

Analysis

The key risk is not the quarter’s isolated EPS decline; it is whether newly recognized credit weakness is spreading through the book. Nonaccrual loans rose while allowance coverage of nonperforming loans fell materially, and substandard balances increased across commercial real estate, construction and C&I. Low current charge-offs are backward-looking; collateral marks, borrower cash flows and migration from special mention are the deciding evidence. Management’s expectation of limited losses is a claim to test, not a loss estimate.

There is an earnings feedback loop: workouts and foreclosed-property costs pressure expenses, nonaccruals remove interest income, and reserve rebuilding further reduces earnings. At the same time, a large share of CDs matures within 12 months and core deposits declined, leaving funding costs exposed if customers continue migrating to higher-rate products. Falling market rates could ease deposit repricing, but may also reduce asset yields; the benefit depends on deposit beta and loan repricing, neither established here.

Capital ratios provide a buffer, but the wider securities unrealized loss and longer duration increase sensitivity to rates and reduce flexibility if liquidity needs rise. Near term, the conference call is the catalyst; over 1–3 months, watch credit classifications, foreclosed-asset costs and deposit retention. Over 6–18 months, sustained commercial credit migration would matter more than this quarter’s single set of relationships. No basis here to claim losses are inevitable or to price a valuation discount without market and collateral data.

Key Decisions for Investors

• Tactically underweight HBCP versus a diversified regional-bank basket such as KRE rather than making a large outright short: the skew is toward further estimate risk if credit costs rise, but capital strength and the possibility of contained workouts limit conviction. Reassess after the October 20 call; keep exposure small absent share-price and valuation context.
• Use the call to seek relationship-level collateral coverage, borrower cash-flow status, vintage/sector concentrations, and expected resolution timing for the new nonaccruals; also ask what drove the foreclosed-asset expense increase. These are decision-critical gaps, not established loss forecasts.
• Track next-quarter criticized/substandard migration, nonaccrual balances, charge-offs and allowance coverage alongside core-deposit balances, CD renewal pricing and NIM. Thesis weakens if credit classifications stabilize, foreclosed costs normalize and core deposits hold; it strengthens if new nonaccruals emerge or funding costs rise despite stable balances.
• Avoid treating capital ratios as proof that AOCI or liquidity risk is immaterial. Monitor rate moves, securities marks and deposit outflows; a material deterioration in any of these would raise the downside beyond ordinary credit normalization.